(Q38028131)

27 August 2017

Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders (English)

1 reference

27 August 2017

1

Ayman W El-Hattab

1 reference

27 August 2017

4

Fernando Scaglia

1 reference

27 August 2017

3

William J Craigen

1 reference

27 August 2017

2

Lisa T Emrick

1 reference

27 August 2017

6 July 2012

1 reference

Molecular Genetics and Metabolism

27 August 2017

1 reference

27 August 2017

107

1 reference

27 August 2017

3

1 reference

27 August 2017

247-252

1 reference

Mitochondrial diseases in man and mouse

27 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

The role of nitric oxide in muscle fibers with oxidative phosphorylation defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

L-arginine improves the symptoms of strokelike episodes in MELAS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Endothelial dysfunction in MELAS improved by l-arginine supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

MELAS and L-arginine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Arginine metabolism: nitric oxide and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Arginine: biochemistry, physiology, and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

The metabolic basis of arginine nutrition and pharmacotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Arginine metabolism: boundaries of our knowledge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Almost all about citrulline in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Citrulline: a new player in the control of nitrogen homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Intestinal mucosal amino acid catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Mammalian urea cycle enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Regulation of enzymes of urea and arginine synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Regulation of nitric oxide production by arginine metabolic enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Requirement of argininosuccinate lyase for systemic nitric oxide production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

The pharmacology of nitric oxide in the peripheral nervous system of blood vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Effect of exercise training on endothelium-derived nitric oxide function in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Mitochondrial biology, degenerative diseases and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Cellular ADMA: regulation and action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Local inhibition of nitric oxide and prostaglandins independently reduces forearm exercise hyperaemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Mitochondrial diabetes: molecular mechanisms and clinical presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Hemodynamic actions of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

New indications and controversies in arginine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Pharmacokinetics of arginine and related amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2012.06.018

10.1016/J.YMGME.2012.06.018

7 January 2021

Identifiers

DOI

1 reference

release_xyf4ht5tmnfrxjhv5oeosqpmci

27 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xyf4ht5tmnfrxjhv5oeosqpmci

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

22819233

1 reference

PubMed ID

22819233